Sort
10,766 grants matching “checkpoint inhibitor”
Collaborative Project
$374,678Jeremy M. Boss · Emory University · U19 · FY2021 · AI
Pertussis inflammation is mediated by a balance between peptidoglycan recognition proteins-1 and -4
$374,663Ciaran Skerry · University Of Maryland Baltimore · R01 · FY2025 · AI
"Optimizing synthetic lethality in high-grade serous ovarian cancer"
$374,652Fiona Simpkins · Johns Hopkins University · P50 · FY2018 · CA
Role of intratumoral high endothelial venules in tumor immunity
$374,578Masanobu Komatsu · Johns Hopkins University · R01 · FY2022 · CA
Role of intratumoral high endothelial venules in tumor immunity
$374,578Masanobu Komatsu · Johns Hopkins University · R01 · FY2025 · CA
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System
$374,578James T. Stivers · Johns Hopkins University · R01 · FY2021 · CA
Discovery of Chemical Probes of SAMHD1 for Modulation of Cancer Therapy and the Immune System
$374,578James T. Stivers · Johns Hopkins University · R01 · FY2020 · CA
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$374,578Drew M. Pardoll · Johns Hopkins University · R01 · FY2021 · CA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$374,436Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2022 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$374,372Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2022 · CA
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
$374,169David McDermott · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
$374,084Rugang Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Gene expression signature based screening in Ewing sarcoma
$373,823David J Gordon · University Of Iowa · R37 · FY2022 · CA
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging
$373,817Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
$373,817Susan M Kaech · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG
Targeting cellular double-stranded RNA homeostasis in breast cancer
$373,774Cecil Han · Georgetown University · R01 · FY2022 · CA
Targeting cellular double-stranded RNA homeostasis in breast cancer
$373,774Cecil Han · Georgetown University · R01 · FY2021 · CA
Targeting cellular double-stranded RNA homeostasis in breast cancer
$373,774Cecil Han · Georgetown University · R01 · FY2025 · CA
Translational Events in Platelets
$373,750Andrew Scott Weyrich · University Of Utah · R01 · FY2009 · HL
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$373,701Katherine B Chiappinelli · George Washington University · R37 · FY2022 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$373,697Everett Stone · University Of Texas At Austin · R01 · FY2019 · CA
Reprogramming myeloid cells to inhibit cancer development
$373,643Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2025 · CA
Regulation of Tumor Microenvironment in Cancer
$373,604Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2015 · CA
Sensitizing high grade serous cancers to immunotherapy through the induction of DNA damage
$373,561Karen McLean · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Gene Expression Signature Based Screening in Ewing Sarcoma
$373,551David J Gordon · University Of Iowa · R37 · FY2023 · CA